Table 2.
AS/AQ (fixed) N = 373 | AS+AQ (loose) N = 375 | |||
Age* |
AS median (range) |
AQ median (range) |
AS median (range) |
AQ median (range) |
0–11 months | 3.57 (2.50 – 5.56) N = 54 | 9.64 (6.75 – 15.00) N = 54 | 3.57 (2.50 – 6.85) N = 59 | 10.86 (7.60 – 20.96) N = 59 |
12+ months | 4.67 (1.79 – 10.00) N = 319† | 12.62 (4.82 – 27.00) N = 319† | 4.72 (2.50 – 10.00) N = 316 | 14.44 (7.65 – 30.60) N = 316 |
* Median doses for AS and AQ were significantly (p < 0.0001) higher comparing children <12 vs. ≥ 12 months.
† The weights of 2 patients (19 months old and 42 months old) assigned to the AS/AQ treatment group were not available. Both patients received 2 tablets at 25/67.5 mg each on D0